I will discuss off-patent drugs in my own speech, but on bisphosphonates, which are in the category of repurposed drugs, is my
hon. Friend as concerned as I am about the UK-wide survey undertaken by the UK Breast Cancer Group in March last year, which showed that currently only 24% of breast cancer clinicians are offering bisphosphonates to patients? That is something that the Government could urgently address.